Search research articles
Contact Us
Filters
Showing results (261-270 of 359) with videos related to
Page
of 36
Sort By:
Aging & Mental Health
|
June 9, 2016
Identifying frailty risk profiles of home-dwelling older people: focus on sociodemographic and socioeconomic characteristics
Sarah Dury, Ellen De Roeck, Daan Duppen, et al.
Neurology
|
November 20, 2015
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort
Ilse Gijselinck, Sara Van Mossevelde, Julie van der Zee, et al.
Acta Neurologica Belgica
|
October 7, 2017
Alzheimer's disease and driving: review of the literature and consensus guideline from Belgian dementia experts and the Belgian road safety institute endorsed by the Belgian Medical Association
Jan Versijpt, Mark Tant, Ingo Beyer, et al.
Alzheimer'S Research & Therapy
|
January 23, 2024
Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method
Amber Nous, Laura Seynaeve, Odile Feys, et al.
Acta Neuropathologica Communications
|
November 12, 2015
Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains
Jonathan Janssens, Stéphanie Philtjens, Gernot Kleinberger, et al.
Journal of Alzheimer'S Disease : JAD
|
May 22, 2018
A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER)
Ellis Niemantsverdriet, Annemie Ribbens, Christine Bastin, et al.
Human Mutation
|
March 9, 2007
Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia
Julie van der Zee, Isabelle Le Ber, Sebastian Maurer-Stroh, et al.
EMBO Molecular Medicine
|
March 5, 2016
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers
Marc Suárez-Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero, et al.
Neurobiology of Aging
|
April 14, 2018
Clinical variability and onset age modifiers in an extended Belgian GRN founder family
Eline Wauters, Sara Van Mossevelde, Kristel Sleegers, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 4, 2024
Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of Frontotemporal Dementia
Yanaika S Hok-A-Hin, Lisa Vermunt, Carel F W Peeters, et al.
Page
of 36
Search research articles
Search
Showing results (261-270 of 359) with videos related to
Sort By:
Page
of 36
Aging & Mental Health
|
June 9, 2016
Identifying frailty risk profiles of home-dwelling older people: focus on sociodemographic and socioeconomic characteristics
Sarah Dury, Ellen De Roeck, Daan Duppen, et al.
Neurology
|
November 20, 2015
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort
Ilse Gijselinck, Sara Van Mossevelde, Julie van der Zee, et al.
Acta Neurologica Belgica
|
October 7, 2017
Alzheimer's disease and driving: review of the literature and consensus guideline from Belgian dementia experts and the Belgian road safety institute endorsed by the Belgian Medical Association
Jan Versijpt, Mark Tant, Ingo Beyer, et al.
Alzheimer'S Research & Therapy
|
January 23, 2024
Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method
Amber Nous, Laura Seynaeve, Odile Feys, et al.
Acta Neuropathologica Communications
|
November 12, 2015
Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains
Jonathan Janssens, Stéphanie Philtjens, Gernot Kleinberger, et al.
Journal of Alzheimer'S Disease : JAD
|
May 22, 2018
A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER)
Ellis Niemantsverdriet, Annemie Ribbens, Christine Bastin, et al.
Human Mutation
|
March 9, 2007
Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia
Julie van der Zee, Isabelle Le Ber, Sebastian Maurer-Stroh, et al.
EMBO Molecular Medicine
|
March 5, 2016
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers
Marc Suárez-Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero, et al.
Neurobiology of Aging
|
April 14, 2018
Clinical variability and onset age modifiers in an extended Belgian GRN founder family
Eline Wauters, Sara Van Mossevelde, Kristel Sleegers, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 4, 2024
Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of Frontotemporal Dementia
Yanaika S Hok-A-Hin, Lisa Vermunt, Carel F W Peeters, et al.
Page
of 36